TB Clinical Diagnostics Research Consortium

结核病临床诊断研究联合会将在结核病流行国家建立一个地点联合会，以便在现有结核病诊断或排除临床算法的背景下评价诊断测试和战略。该联盟将提供一种诊断开发的综合方法，允许在结核病流行环境中评估有前途的新诊断，并允许诊断开发人员和临床医生之间进行必要的直接沟通，以确保新的诊断测试显着有助于改善结核病的诊断和推进该疾病的临床护理。 该联盟还将向结核病社区提供资源，供外部研究人员获得有关结核病诊断发展的信息。

The TB Clinical Diagnostics Research Consortium will establish a consortium of sites in TB endemic countries for the purpose of evaluating diagnostic tests and strategies in the context of existing clinical algorithms for diagnosis or exclusion of TB. The consortium will provide an integrated approach to diagnostic development, allowing promising new diagnostics to be evaluated in a TB endemic setting and allowing for direct communications between diagnostic developers and clinicians as necessary to assure a new diagnostic test significantly contributes to improving diagnosis of TB and advancing clinical care for the disease. The consortium will also provide a resource to the TB community for outside investigators to obtain information about TB diagnostic development.